famotidine has been researched along with Pancreatitis in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease." | 5.31 | [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis]. ( Bagnenko, SF; Gol'tsov, VR; Nazarov, VE; Rukhliada, NV; Tolstoĭ, AD, 2002) |
| "The aim of the study was to assess effects of H2-blocker of the IIId generation famotidine (quamatel) on the progression of acute and chronic pancreatitis and intensity of pain in patients with pancreatitis." | 5.09 | [Quamatel in the treatment of acute and chronic pancreatitis]. ( Belousova, EA; Dolgova, MB; Filizhanko, VN; Lovakov, AI; Nikulin, IV; Shemeneva, EG; Zlatkin, AR, 2000) |
| "We report a case of acute pancreatitis, which occurred after delivery in a woman who had an uneventful course of pregnancy and parturition." | 1.32 | Acute pancreatitis occurring in the early postpartum period: a case report. ( Chaen, H; Eguchi, F; Fukami, T; Imura, H; Sudou, K, 2003) |
| "In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease." | 1.31 | [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis]. ( Bagnenko, SF; Gol'tsov, VR; Nazarov, VE; Rukhliada, NV; Tolstoĭ, AD, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nichitaĭlo, ME | 1 |
| Bagnenko, SF | 1 |
| Rukhliada, NV | 1 |
| Tolstoĭ, AD | 1 |
| Gol'tsov, VR | 1 |
| Nazarov, VE | 1 |
| Fukami, T | 1 |
| Chaen, H | 1 |
| Imura, H | 1 |
| Sudou, K | 1 |
| Eguchi, F | 1 |
| Osipenko, MF | 1 |
| Venzhina, IuIu | 1 |
| Belousova, EA | 1 |
| Zlatkin, AR | 1 |
| Nikulin, IV | 1 |
| Lovakov, AI | 1 |
| Filizhanko, VN | 1 |
| Shemeneva, EG | 1 |
| Dolgova, MB | 1 |
1 trial available for famotidine and Pancreatitis
| Article | Year |
|---|---|
[Quamatel in the treatment of acute and chronic pancreatitis].
Topics: Acute Disease; Adult; Chronic Disease; Disease Progression; Famotidine; Female; Histamine H2 Antagon | 2000 |
4 other studies available for famotidine and Pancreatitis
| Article | Year |
|---|---|
[Prophylaxis of an acute postoperative pancreatitis and the stress ulcers occurrence after operations, performed on organs of hepatopancreatoduodenal zone, using miniinvasive and open access].
Topics: Acute Disease; Drug Administration Schedule; Drug Dosage Calculations; Duodenal Ulcer; Endoscopy, Ga | 2014 |
[Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis].
Topics: Acute Disease; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Pa | 2002 |
Acute pancreatitis occurring in the early postpartum period: a case report.
Topics: Abdominal Pain; Acute Disease; Adolescent; Back Pain; Famotidine; Female; Gabexate; Histamine H2 Ant | 2003 |
[Problems of excretory insufficiency of the pancreas].
Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle A | 2004 |